Living with multiple sclerosis (MS) involves navigating many changes as the body ages. For women, reaching menopause often brings questions about how hormonal shifts might change their disease activity or physical progress. However, recent evidence suggests that while symptoms may become more difficult to manage during midlife, menopause itself is not a distinct biological turning point for MS progression.
Researchers looked at several factors, including relapse activity and inflammation shown on scans. They found no clear evidence that menopause causes a sudden shift in these areas. Additionally, when looking at physical disability scores, the impact of menopause was not clearly different from the general effects of getting older.
There is some emerging data suggesting that reproductive aging might be linked to increased nerve vulnerability, but these findings are still limited and need more study. While hormone therapy can help improve daily symptoms for many women, its specific effect on the overall course of MS remains uncertain. Doctors suggest a menopause-aware approach to ensure patients get the right support as they age.
